(Q37425253)

20 August 2017

1 reference

title

Dipeptidyl-peptidase IV and B-type natriuretic peptide. From bench to bedside (English)

1 reference

20 August 2017

Anne-Marie Lambeir

5

0 references

Ingrid De Meester

object named as

Ingrid De Meester

6

0 references

author name string

Marc Vanderheyden

1

1 reference

20 August 2017

Jozef Bartunek

2

1 reference

20 August 2017

Marc Goethals

3

1 reference

20 August 2017

Sofie Verstreken

4

1 reference

20 August 2017

Simon Scharpé

7

1 reference

20 August 2017

1 January 2009

1 reference

Clinical Chemistry and Laboratory Medicine

20 August 2017

1 reference

20 August 2017

47

1 reference

20 August 2017

3

1 reference

20 August 2017

248-252

1 reference

International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey

20 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

State of the art: using natriuretic peptide levels in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Brain and other natriuretic peptides: molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Neuropeptide secretion in exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Determinants of inducible brain natriuretic peptide promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Relevance of molecular forms of brain natriuretic peptide for natriuretic peptide research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Review of 10 years of the clinical use of brain natriuretic peptide in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Molecular biology of natriuretic peptides and nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

CD26, let it cut or cut it down.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Characterization of molecular forms of probrain natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.065

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.065

1 reference

20 August 2017

1 reference